SubscribeThe development of effective new vaccines is dependent upon the body being able to generate immune responses to the components of the vaccine that will confer protection against the infectious agents.
The quantitative and qualitative measurement of such responses is part of a comprehensive package of services that the Agency is able to offer to government, academia and industry.
We offer a wide range of services from the development of assays right through to work to support vaccine clinical trials.